These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 22956765

  • 1. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
    Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD.
    Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
    [Abstract] [Full Text] [Related]

  • 2. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin.
    Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ.
    J Biol Chem; 2000 Feb 25; 275(8):5983-6. PubMed ID: 10681592
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
    Hatanaka K, Lanahan AA, Murakami M, Simons M.
    PLoS One; 2012 Feb 25; 7(5):e37600. PubMed ID: 22629427
    [Abstract] [Full Text] [Related]

  • 4. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.
    Grinnell KL, Casserly B, Harrington EO.
    Am J Physiol Lung Cell Mol Physiol; 2010 Mar 25; 298(3):L361-70. PubMed ID: 20023173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB.
    Circ Res; 2012 Aug 31; 111(6):739-49. PubMed ID: 22798526
    [Abstract] [Full Text] [Related]

  • 8. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
    Zhang J, Huang J, Qi T, Huang Y, Lu Y, Zhan T, Gong H, Zhu Z, Shi Y, Zhou J, Yu L, Zhang X, Cheng H, Ke Y.
    FASEB J; 2019 Jan 31; 33(1):1124-1137. PubMed ID: 30102570
    [Abstract] [Full Text] [Related]

  • 9. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
    Chattopadhyay R, Raghavan S, Rao GN.
    Redox Biol; 2017 Aug 31; 12():438-455. PubMed ID: 28319894
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
    Hatanaka K, Simons M, Murakami M.
    Am J Physiol Heart Circ Physiol; 2011 Jan 31; 300(1):H162-72. PubMed ID: 21037229
    [Abstract] [Full Text] [Related]

  • 11. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca2+ entry regulates disassembly of adherens junctions.
    Soni D, Regmi SC, Wang DM, DebRoy A, Zhao YY, Vogel SM, Malik AB, Tiruppathi C.
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun 01; 312(6):L1003-L1017. PubMed ID: 28385807
    [Abstract] [Full Text] [Related]

  • 12. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
    Adam AP, Sharenko AL, Pumiglia K, Vincent PA.
    J Biol Chem; 2010 Mar 05; 285(10):7045-55. PubMed ID: 20048167
    [Abstract] [Full Text] [Related]

  • 13. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration.
    Allingham MJ, van Buul JD, Burridge K.
    J Immunol; 2007 Sep 15; 179(6):4053-64. PubMed ID: 17785844
    [Abstract] [Full Text] [Related]

  • 14. Distribution of adherens junction mediated by VE-cadherin complex in rat spleen sinus endothelial cells.
    Uehara K.
    Cell Tissue Res; 2006 Mar 15; 323(3):417-24. PubMed ID: 16244888
    [Abstract] [Full Text] [Related]

  • 15. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.
    Alcaide P, Martinelli R, Newton G, Williams MR, Adam A, Vincent PA, Luscinskas FW.
    Am J Physiol Cell Physiol; 2012 Aug 15; 303(4):C385-95. PubMed ID: 22648953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. M3 muscarinic acetylcholine receptor dysfunction inhibits Rac1 activity and disrupts VE-cadherin/β-catenin and actin cytoskeleton interaction.
    Jiao ZY, Wu J, Wen B, Zhao WZ, Du XL.
    Biochem Cell Biol; 2014 Apr 15; 92(2):137-44. PubMed ID: 24697698
    [Abstract] [Full Text] [Related]

  • 18. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, Guha S, Cox CS, Reitz MS, Holcomb JB, Dash PK.
    Stem Cells Dev; 2011 Jan 15; 20(1):89-101. PubMed ID: 20446815
    [Abstract] [Full Text] [Related]

  • 19. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function.
    Seebach J, Mädler HJ, Wojciak-Stothard B, Schnittler HJ.
    Thromb Haemost; 2005 Sep 15; 94(3):620-9. PubMed ID: 16268481
    [Abstract] [Full Text] [Related]

  • 20. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I, Louzao-Martinez L, Brandt M, van Dijk CGM, Burgisser P, Zhu C, Kros JM, Duncker DJ, Cheng C.
    Arterioscler Thromb Vasc Biol; 2017 Jun 15; 37(6):1098-1114. PubMed ID: 28428220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.